Given the critical role of telomere maintenance in regulating tumor cell proliferation and invasion, we investigated its involvement in KPNA2-mediated HCC progression by treating HCC cells with the telomerase inhibitor BIBR1532, a well-characterized small molecule inhibitor of telomerase. This evidence concerns the gene KPNA2 and hepatocellular carcinoma.